Literature DB >> 21067427

Herb-drug pharmacokinetic interactions reviewed.

Clemence Tarirai1, Alvaro M Viljoen, Josias H Hamman.   

Abstract

IMPORTANCE OF THE FIELD: the global increase in the popularity of alternative medicines has raised renewed concerns regarding herb-drug interactions. These interactions are especially important for drugs with narrow therapeutic indices and may either be pharmacodynamic or pharmacokinetic in nature. AREAS COVERED IN THIS REVIEW: pharmacokinetic interactions which may exist between herbs and drugs, and the mechanisms of these interactions with appropriate examples based on primary and secondary data in publications are discussed. The mechanisms covered include those that affect oral drug absorption (e.g., modulation of efflux and uptake transporters, complex formation, gastrointestinal motility and pH) and drug biotransformation (e.g., inhibition or induction of enzymes). WHAT THE READER WILL GAIN: knowledge on the mechanisms of herb-drug pharmacokinetic interactions supported by an extended list of these types of interactions for quick reference. A critical evaluation of certain herb-drug pharmacokinetic interactions reported in the scientific literature. TAKE HOME MESSAGE: as the incidence and severity of herb-drug pharmacokinetic interactions increase due to a worldwide rise in the use of herbal preparations, more clinical data regarding herb-drug pharmacokinetic interactions are needed to make informed decisions regarding patient safety.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067427     DOI: 10.1517/17425255.2010.529129

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  11 in total

Review 1.  Drug interactions with herbal medicines.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2012-02-01       Impact factor: 6.447

Review 2.  Addressing phenoconversion: the Achilles' heel of personalized medicine.

Authors:  Rashmi R Shah; Robert L Smith
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

3.  Herbal medicine use among Type 2 diabetes mellitus patients in Nigeria: understanding the magnitude and predictors of use.

Authors:  Ogochukwu Ukamaka Amaeze; Roseline Iberi Aderemi-Williams; Modupeola Anuoluwapo Ayo-Vaughan; Deborah Aderoju Ogundemuren; Damilola Segun Ogunmola; Emmanuel Nwanolue Anyika
Journal:  Int J Clin Pharm       Date:  2018-05-02

4.  Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects.

Authors:  Fahad Ibrahim Al-Jenoobi; Areej A Al-Thukair; Mohd Aftab Alam; Fawkeya A Abbas; Abdullah M Al-Mohizea; Khalid M Alkharfy; Saleh A Al-Suwayeh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-02-09       Impact factor: 2.441

5.  A six-month supplementation of mulberry, korean red ginseng, and banaba decreases biomarkers of systemic low-grade inflammation in subjects with impaired glucose tolerance and type 2 diabetes.

Authors:  H-J Kim; K-H Yoon; M-J Kang; H-W Yim; K-S Lee; V Vuksan; M-K Sung
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-28       Impact factor: 2.629

Review 6.  An Overview of the Evidence and Mechanism of Drug-Herb Interactions Between Propolis and Pharmaceutical Drugs.

Authors:  Sanowar Hossain; Muhammad Yousaf; Yang Liu; Dennis Chang; Xian Zhou
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

7.  Effects of Nigella sativa and Lepidium sativum on cyclosporine pharmacokinetics.

Authors:  F I Al-Jenoobi; S A Al-Suwayeh; Iqbal Muzaffar; Mohd Aftab Alam; Khalid M Al-Kharfy; Hesham M Korashy; Abdullah M Al-Mohizea; Abdul Ahad; Mohd Raish
Journal:  Biomed Res Int       Date:  2013-07-16       Impact factor: 3.411

Review 8.  Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases.

Authors:  Gregory Ondieki; Makafui Nyagblordzro; Siambi Kikete; Rongjia Liang; Lili Wang; Xin He
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-31       Impact factor: 2.629

9.  Negligible Effect of Quercetin in the Pharmacokinetics of Sulfasalazine in Rats and Beagles: Metabolic Inactivation of the Interaction Potential of Quercetin with BCRP.

Authors:  Ju-Hee Oh; Dokeun Kim; Haejun Lee; Gyeonghee Kim; Taehoon Park; Min Chang Kim; Young-Joo Lee
Journal:  Pharmaceutics       Date:  2021-11-23       Impact factor: 6.321

Review 10.  Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs.

Authors:  Raymond E Lai; Christopher E Jay; Douglas H Sweet
Journal:  J Food Drug Anal       Date:  2018-03-24       Impact factor: 6.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.